South Shore Neurologic Associates

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Multiple sclerosis2 trials
• Alzheimer disease1 trial
• Parkinson disease1 trial

Phase

• Phase 33 trials

Status

• Active, not recruiting3 trials
• Completed1 trial

Lead sponsor

• Novartis Pharmaceuticals2 trials
• CENTOGENE GmbH Rostock1 trial
• Eli Lilly and Company1 trial

Running trials

• Active, not recruiting

  Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab

  NCT06869785· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

  NCT05156281· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)

  NCT05026866· Phase 3· Eli Lilly and Company· Source

Closed trials

• Completed

  Rostock International Parkinson's Disease Study (ROPAD)

  NCT03866603· CENTOGENE GmbH Rostock· Source